The RNV scan is a gold-standard test to assess the left ventricle function before and during the cardiotoxic chemotherapy treatment. Additionally, it has shown itself to be a cost-effective test for ventricular function monitoring during cardiotoxic chemotherapy.

The regional wall motion abnormality reported on scan could signal towards coronary ischemia or infarction. Additionally, it can provide prognostic information for coronary artery disease and an acute coronary event.